MENJUGATE: Clinical Trials

1 trial of MENJUGATE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow MENJUGATE: new trials by email Literature Review of MENJUGATE trials Research Report on MENJUGATE

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos
'MenCC-Bio', MENJUGATE - Meningitis, Meningococcal, Serogroup C
Phase 1CompletedThe Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)602014-05-012015-09-16

Conditions studied

Meningitis, Meningococcal (1)

Sponsors

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (1)

Countries

Brazil (1)